Compound B as angiogenic agent in combination with human growth factors
US6855684B2 · kind B2 · utility
1Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2001 |
| Grant date | Feb 15, 2005 |
| Priority date | — |
| Expiry date | Sep 28, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention refers to the use of Compound B as angiogenic agent in combination with human growth factors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.